World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
15938
World Ranking
2246
National Ranking
1085

Overview

Donald F. Smee is a researcher affiliated with Utah State University in the United States. Their work primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Infectious Diseases, Molecular Biology, Epidemiology, Biotechnology, and Virology.

The scientist has contributed to studies on a range of topics including:

  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Transgenic Plants and Applications
  • Vaccines and Immunoinformatics Approaches
  • Poxvirus Research and Outbreaks
  • Herpesvirus Infections and Treatments
  • Bacillus and Francisella Bacterial Research

Frequent coauthors collaborating with Donald F. Smee include E. Bart Tarbet, David M. Markovitz, Brett L. Hurst, Craig W. Day, and Ralph S. Baric.

The researcher has published articles in several venues with repeated publications in UNC Libraries, Antiviral Research, Proceedings of the National Academy of Sciences, and Virology.

Notable recent papers authored or coauthored by Donald F. Smee include:

  • A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo, 2020, Proceedings of the National Academy of Sciences
  • A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge, 2021, Antiviral Research
  • Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus, 2020, Antiviral Research
  • Human IVIG treatment in a neurological disease model for Enterovirus A71 infection in 28-day-old AG129 mice, 2023, Virology
  • A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo, 2020, UNC Libraries

Best Publications

  • Favipiravir (T-705), a novel viral RNA polymerase inhibitor.

    Yousuke Furuta;Brian B. Gowen;Kazumi Takahashi;Kimiyasu Shiraki

  • T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

    Yousuke Furuta;Kazumi Takahashi;Kimiyasu Shiraki;Kenichi Sakamoto

  • 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent

    John C. Martin;Charles A. Dvorak;Donald F. Smee;Thomas R. Matthews

  • Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

    D F Smee;J C Martin;J P Verheyden;T R Matthews

  • Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders.

    S. Hossein Fatemi;Teri J. Reutiman;Timothy D. Folsom;Hao Huang

  • Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection

    Michael P. Malakhov;Laura M. Aschenbrenner;Donald F. Smee;Miles K. Wandersee

  • Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus Challenge

    Mike Bray;Mark Martinez;Donald F. Smee;Debbie Kefauver

  • Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin

    Barry R. O'Keefe;Donald F. Smee;Jim A. Turpin;Carrie J. Saucedo

  • Viruses of the Bunya- and Togaviridae families: potential as bioterrorism agents and means of control

    Robert W Sidwell;Donald F Smee

  • Identification of active antiviral compounds against a New York isolate of West Nile virus

    John D Morrey;Donald F Smee;Robert W Sidwell;Christopher Tseng

  • Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro

    Jack T. Nguyen;Justin D. Hoopes;Minh H. Le;Donald F. Smee

  • Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities

    Donald F. Smee;John H. Huffman;A. N. N. C. Morrison;Dale L. Barnard

  • PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication

    Angela M. Lam;Eisuke Murakami;Christine Espiritu;Holly M. Micolochick Steuer

  • A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

    Craig W. Day;Ralph Baric;Sui Xiong Cai;Matt Frieman

  • SP-303, an antiviral oligomeric proanthocyanidin from the latex of Croton lechleri (Sangre de Drago).

    R. Ubillas;S.D. Jolad;R.C. Bruening;M.R. Kernan

  • Inhibition of Severe Acute Respiratory Syndrome-Associated Coronavirus (SARSCoV) by Calpain Inhibitors and Beta-D-N4-Hydroxycytidine

    Dale L Barnard;Valerie D Hubbard;Jared Burton;Donald F Smee

  • The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

    Eve Isabelle Pécheur;Viktoriya Borisevich;Peter Halfmann;John D. Morrey

  • Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice

    Robert W. Sidwell;Dale L. Barnard;Craig W. Day;Donald F. Smee

  • Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells.

    Donald F. Smee;Richard Boehme;Marlene Chernow;Bridget P. Binko

  • Immunotherapeutic activity of a conjugate of a Toll-like receptor 7 ligand.

    Christina C. N. Wu;Tomoko Hayashi;Kenji Takabayashi;Mojgan Sabet

Frequent Co-Authors

Robert W. Sidwell
Robert W. Sidwell Utah State University
John D. Morrey
John D. Morrey Utah State University
Roland K. Robins
Roland K. Robins University of Utah
John W. Huggins
John W. Huggins United States Department of the Army
Chung K. Chu
Chung K. Chu University of Georgia
Mike Bray
Mike Bray National Institutes of Health
Karl Y. Hostetler
Karl Y. Hostetler University of California, San Diego
Colleen B. Jonsson
Colleen B. Jonsson University of Tennessee Health Science Center
Barry R. O'Keefe
Barry R. O'Keefe National Institutes of Health
Christine Winter
Christine Winter Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare careers can open diverse opportunities. Many graduates consider advancing into nursing roles, where specialized knowledge of the immune system is invaluable.

One popular option is to pursue programs like the cheapest psych np programs. These affordable pathways enable students to specialize in psychiatric care, blending immunological principles with mental health treatment.

Nurse practitioners often evaluate potential earnings before committing to programs. Understanding how much do dnps make in different states helps inform career decisions and geographic preferences.

For nurses already practicing as Family Nurse Practitioners, transitioning to acute care through structured acnp programs can expand clinical expertise and job prospects, especially in specialized immunology-related fields like infectious disease and oncology.

Additionally, accelerated pathways such as the accelerated np programs offer fast-tracked routes to advanced practice nursing roles, helping graduates quickly enter vital immunology-associated healthcare roles.

Best Scientists Citing Donald F. Smee

Trending Scientists